CXCL1 and type 2 diabetes mellitus: Addition of the MMP-2/MMP-9 inhibitor BiPS (25 μM) reduced tube formation in response to both [ND- GROα] (p < 0.0001) and [T2D- GROα] (p < 0.05) in T2D-AT-EC.